Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Arcadia Biosciences (RKDA) Profit After Tax (2016 - 2025)

Arcadia Biosciences' Profit After Tax history spans 12 years, with the latest figure at -$1.3 million for Q4 2025.

  • For Q4 2025, Profit After Tax rose 80.23% year-over-year to -$1.3 million; the TTM value through Dec 2025 reached -$2.3 million, up 72.52%, while the annual FY2025 figure was -$2.3 million, 66.77% up from the prior year.
  • Profit After Tax reached -$1.3 million in Q4 2025 per RKDA's latest filing, down from $856000.0 in the prior quarter.
  • In the past five years, Profit After Tax ranged from a high of $144.0 million in Q2 2021 to a low of -$9.4 million in Q1 2023.
  • Average Profit After Tax over 5 years is $4.8 million, with a median of -$2.5 million recorded in 2023.
  • Peak YoY movement for Profit After Tax: surged 1555.57% in 2021, then plummeted 374.24% in 2022.
  • A 5-year view of Profit After Tax shows it stood at -$7.5 million in 2021, then soared by 43.41% to -$4.2 million in 2022, then surged by 32.89% to -$2.8 million in 2023, then plummeted by 137.29% to -$6.8 million in 2024, then surged by 80.23% to -$1.3 million in 2025.
  • Per Business Quant, the three most recent readings for RKDA's Profit After Tax are -$1.3 million (Q4 2025), $856000.0 (Q3 2025), and -$4.5 million (Q2 2025).